What is NDC 70010-214?

70010-214 is the product NDC for Lisdexamfetamine dimesylate, Lisdexamfetamine dimesylate 10 mg/1 tablet, chewable, listed with the FDA by Granules Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Granules Pharmaceuticals Inc., NDC labeler code 70010. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lisdexamfetamine dimesylate?

159 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lisdexamfetamine dimesylate NDC 70010-214

NDC codes

FDA NDC Directory

Product NDC (as listed)70010-214Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70010-0214Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70010-214-01	7001002140170010021401	100 TABLET, CHEWABLE in 1 BOTTLE (70010-214-01)Marketed from Dec 17, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisdexamfetamine dimesylate
Generic name (nonproprietary): lisdexamfetamine dimesylate
Active ingredients: Lisdexamfetamine dimesylate — 10 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: Granules Pharmaceuticals Inc.NDC labeler code 70010
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219258
Marketing start: Dec 17, 2024
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 70010-214_5b7f44b7-f69e-f96d-e063-6294a90a217aSPL ID 5b7f44b7-f69e-f96d-e063-6294a90a217a
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470010021401 followed by a unit qualifier and the quantity

Package 70010-0214-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 70010-214

What is NDC 70010-214?: 70010-214 is the product NDC for Lisdexamfetamine dimesylate, Lisdexamfetamine dimesylate 10 mg/1 tablet, chewable, listed with the FDA by Granules Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lisdexamfetamine dimesylate.
What is the active ingredient?: Lisdexamfetamine dimesylate.
Who is the labeler?: Granules Pharmaceuticals Inc., NDC labeler code 70010. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lisdexamfetamine dimesylate?: 159 other product NDCs are listed under this name. See all Lisdexamfetamine dimesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lisdexamfetamine dimesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 30 mg/1	CapsuleOral	American Health Packaging	60687-907	60687-0907-21
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 40 mg/1	CapsuleOral	American Health Packaging	60687-918	60687-0918-21
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 70 mg/1	CapsuleOral	American Health Packaging	60687-951	60687-0951-21
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 20 mg/1	CapsuleOral	American Health Packaging	60687-896	60687-0896-21
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 50 mg/1	CapsuleOral	American Health Packaging	60687-929	60687-0929-21
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 60 mg/1	CapsuleOral	American Health Packaging	60687-940	60687-0940-21
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 40 mg/1	CapsuleOral	Sandoz Inc	0781-2478	00781-2478-01
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 50 mg/1	CapsuleOral	Sandoz Inc	0781-2479	00781-2479-01
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 60 mg/1	CapsuleOral	Sandoz Inc	0781-2480	00781-2480-01
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 70 mg/1	CapsuleOral	Sandoz Inc	0781-2481	00781-2481-01

All 160 Lisdexamfetamine dimesylate NDCs

Other NDCs under ANDA 219258

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219258
Product	Strength	Form · route	Labeler	Product NDC
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 20 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-215
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 30 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-216
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 40 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-217
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 50 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-218
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 60 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-219